Key points are not available for this paper at this time.
studies were performed including docking, ADMET, and toxicity studies to predict binding mode against VEGFR-2 and to anticipate pharmacokinetic, drug-likeness, and toxicity of the synthesised compounds.
Hagras et al. (Mon,) studied this question.